Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: The Wisconsin Diabetes Registry Study

American Journal of Epidemiology

Volumn 164, Issue 2, 2006, Pages 143-150

  LeCaire, Tamara ^a   Palta, Mari ^a   Zhang, Hongling ^b   Allen, Catherine ^a   Klein, Ronald ^a   D'Alessio, Donn ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b 206 Carnegie Center   (United States)

Author keywords

Diabetes mellitus, type 1; Diabetic retinopathy; Longitudinal studies; Risk factors

Indexed keywords

INSULIN;

DIABETES; DISEASE PREVALENCE; DISEASE SEVERITY; HEALTH RISK;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DEMOGRAPHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REGISTER; RISK FACTOR; SELF CARE; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WISCONSIN;

NORTH AMERICA; UNITED STATES; WISCONSIN;

EID: 33745591100     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj166     Document Type: Article

References (32)

1. Bode BW, ed. Medical management of type 1 diabetes. 4th ed. Alexandria, VA: American Diabetes Association, 2004.
2. Klein R, Klein BBK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
3. Burger W, Hövener G, Düsterhus R, et al. Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study. Diabetologia 1986;29:17-22.
4. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 1993;100:1125-31.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. Henricsson M, Nyström L, Blohmé G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003;26:349-54.
7. Klein R. Has the frequency of proliferative diabetic retinopathy declined in the U.S.? Diabetes Care 2003;26:2691-2.
8. Palta M, LeCaire T, Daniels K, et al. Risk factors for hospitalization in a cohort with type 1 diabetes. Am J Epidemiol 1997;146:627-36.
9. Stevens G, Cho JH. Socioeconomic indexes and the new 1980 Census occupational classification scheme. Soc Sci Res 1985;14:142-68.
10. Duck SC, Lee M, D'Alessio D. 24-42 month stability of internal blood standards for glycated hemoglobin analysis. Diabetes Res Clin Pract 1990;9:195-9.
11. Palta M, Shen G, Allen C, et al. Longitudinal glycosylated hemoglobin patterns from diagnosis in a population based cohort of IDDM. Am J Epidemiol 1996;144:954-61.
12. Writing Committee on behalf of the HDFP Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med 1976;5:207-15.
13. Klein R, Palta M, Allen C, et al. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol 1997;115:351-6.
14. SAS Institute, Inc. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, Inc, 1999.
15. Robins JM, Rotnitzky A, Zhao LP. Analysis of semiparametric regression models in the presence of missing data. JAMA 1995;90:106-21.
16. Palta M. Application of weighting with probability sampling and nonresponse. In: Quantitative methods in population health: extensions of ordinary regression. Hoboken, NJ: John Wiley and Sons, Inc, 2003:97-109.
17. Hogan JW. GEE and missing data in longitudinal studies. In: Lenderking WR, Revicki DA, eds. Advancing health outcomes research methods and clinical applications. McLean, VA: Degnon Associates, 2005:139-54.
18. Prentice PL, Gloeckler LA. Regression analysis of grouped survival data with applications to breast cancer data. Biometrics 1978;34:57-67.
19. Allison PD. Discrete-time methods for the analysis of event histories. In: Leinhardt S, ed. Sociological methods and research. San Francisco, CA: Jossey-Bass Publishers, 1982: 61-98.
20. Wu MC, Follman DA. Use of summary measures to adjust for informative missingness in repeated measures data with random effects. Biometrics 1999;55:75-84.
21. Park S, Palta M, Shao J, et al. Bias adjustment in analyzing longitudinal data with informative missingness. Stat Med 2002;21:277-91.
22. Klein R, Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1995;155:745-54.
23. Roy MS, Klein R, O'Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004;122:546-51.
24. Kostraba JN, Klein R, Dorman JS, et al. The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991;133:381-91.
25. Falck A, Käär M-L, Laatikainen L. A prospective, longitudinal study examining the development of retinopathy in children with diabetes. Acta Paediatr 1996;85:313-19.
26. Kernell A, Dedorsson I, Johansson B, et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia 1997;40:307-10.
27. Larsson L-I, Alm A, Bergenheim T, et al. Retinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden. Acta Ophthalmol Scand 1999;77:430-6.
28. Danne T, Kordonouri O, Enders I, et al. Monitoring for retinopathy in children and adolescents with type 1 diabetes. Acta Paediatr Suppl 1998;425:35-41.
29. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-83.
30. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-15.
31. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2004;26:1258-64.
32. Olsen BS, Johannesen J, Sjolie AK, et al. Metabolic control and prevalence of microvascular complications in young Danish patients with type 1 diabetes mellitus. Diabet Med 1999;16:79-85.